EUVIMEDEUVIMED entdecken
Metaanalyse

Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis

Mohamad Jamalinia iD, Fatemeh Zare, Alessandro Mantovani, Giovanni Targher iD, Amedeo Lonardo iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16568 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Mohamad Jamalinia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Fatty Liver, Metabolic Diseases. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Since sex is a significant modifier of cardiovascular disease (CVD) and metabolic dysfunction‐associated steatotic liver disease (MASLD), we performed a meta‐analysis to estimate the sex‐specific risk of fatal and non‐fatal CVD events in adults with MASLD. Materials and Methods We searched four major electronic databases from inception to November 2024 to identify observational cohort studies examining sex‐specific associations between MASLD and the risk of fatal and/or non‐fatal CVD events. The diagnosis of MASLD and its severity were assessed using serum biomarkers/scores, International Classification of Diseases codes, imaging or histology.

Results

Thirty‐six cohort studies with aggregate data on ~18.5 million individuals were included (~25% with MASLD; 48% women; mean age of 50.2 years). During a median follow‐up of 6.9 years (IQR 5.0–12.3), approximately 515 000 fatal and/or non‐fatal CVD events occurred (42% in women). MASLD was associated with a higher risk of fatal or non‐fatal CVD events in women (pooled hazard ratio [HR] 1.59, 95% confidence interval [CI] 1.44–1.75; I 2 = 96.10%) than in men (pooled HR 1.37, 95% CI 1.27–1.48; I 2 = 96.26%) ( p ‐value for sex difference = 0.018). The severity of MASLD (variably assessed) further increased the magnitude of this risk, especially in women (pooled HR 2.40, 95% CI 1.73–3.32; I 2 = 57.29%). Sensitivity analyses did not modify these findings. The funnel plot and Egger's test showed no significant publication bias.

Conclusions

Women with MASLD are at higher risk of incident fatal and non‐fatal CVD events compared with men, especially as the severity of MASLD increases. These findings emphasize the necessity for sex‐specific CVD risk assessment and management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesFatty LiverMetabolic DiseasesHumansFemaleMaleSex FactorsRisk FactorsMiddle AgedAdult

Stichwörter der Autor:innen

cardiovascular diseasecardiovascular risk factorsmetabolic syndromenonalcoholic fatty liver diseaseprecision medicinesex differences

Autor:innen und Institutionen

  • Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
  • Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Verona, Italy.
  • Department of Medicine, University of Verona, Verona, Italy.
  • Department of Internal Medicine, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.

ORCID-Profile: Mohamad Jamalinia, Giovanni Targher, Amedeo Lonardo

Zitieren

APA

Jamalinia, M., Zare, F., Mantovani, A., Targher, G., & Lonardo, A. (2025). Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16568

Vancouver

Jamalinia M, Zare F, Mantovani A, Targher G, Lonardo A. Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16568

BibTeX
@article{Jamalinia2025,
  author = {Jamalinia, Mohamad and Zare, Fatemeh and Mantovani, Alessandro and Targher, Giovanni and Lonardo, Amedeo},
  title = {Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16568}
}
Kostenlos starten →